Liver Metastasis Recruiting Phase 3 Trials for Raltitrexed (DB00293)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02453490Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver MetastasisTreatment